Ultimate Guide to Combating Coronavirus Ultimate Guide to Combating Coronavirus

ADVERTISEMENT

EU Infiltrated by Pesticide Industry Plagiarizes Safety Study

Analysis by Dr. Joseph Mercola Fact Checked

glyphosate safety

Story at-a-glance -

  • Researchers accused the German Federal Institute for Risk Assessment (BfR) of plagiarizing an assessment supporting glyphosate’s safety
  • The plagiarized sections were largely lifted from a paper written by the pesticide industry, raising serious concerns about the legitimacy of the findings
  • The scandal asserts that the German risk assessment of glyphosate contains sections “copy pasted” from industry contributions, which likely influenced the EU’s favorable vote to renew the chemical’s license
  • In the chapters assessing published studies on health risks related to glyphosate, 50.1 percent of the content was plagiarized
  • When asked whether BfR’s plagiarism influenced their assessment of glyphosate’s safety, including its potential to cause cancer, the researchers said the answer is a “clear yes”

Controversy over glyphosate has reached an all-time high in the European Union (EU), after researchers accused the German Federal Institute for Risk Assessment (BfR) of plagiarizing a report supporting its safety. The plagiarized sections were largely lifted from a paper written by the pesticide industry, raising serious concerns about the legitimacy of the findings.

The scandal asserts that the German risk assessment of glyphosate, the active ingredient in Roundup herbicide, contains sections "copy pasted" from industry contributions, which likely influenced the EU's favorable vote to renew the chemical's license.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access